Inventor
VENKATESH GOPI M
US44 patents
⚠️ This page may combine multiple inventors who share the name “VENKATESH GOPI M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ADARE PHARMACEUTICALS INC
15 patentsUS9579293B2Feb 28, 2017
Timed, pulsatile release systems
ADARE PHARMACEUTICALS INC25 citations94
US9566249B2Feb 14, 2017
Timed, pulsatile release systems
ADARE PHARMACEUTICALS INC24 citations94
US10045946B2Aug 14, 2018
Timed, pulsatile release systems
ADARE PHARMACEUTICALS INC4 citations84
US9339504B2May 17, 2016
Orally disintegrating tablet compositions of lamotrigine
ADARE PHARMACEUTICALS INC5 citations82
US11147772B2Oct 19, 2021
Timed, pulsatile release systems
ADARE PHARMACEUTICALS INC1 citations73
US10568832B2Feb 25, 2020
Taste-masked pharmaceutical compositions
ADARE PHARMACEUTICALS INC3 citations73
US10500161B2Dec 10, 2019
Timed, pulsatile release systems
ADARE PHARMACEUTICALS INC2 citations73
US10130580B2Nov 20, 2018
Taste-masked pharmaceutical compositions
ADARE PHARMACEUTICALS INC3 citations73
US10952971B2Mar 23, 2021
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
ADARE PHARMACEUTICALS INC3 citations72
US10471017B2Nov 12, 2019
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
ADARE PHARMACEUTICALS INC3 citations72
US9730896B2Aug 15, 2017
Orally disintegrating tablets and methods of manufacture
ADARE PHARMACEUTICALS INC3 citations70
US11160772B2Nov 2, 2021
Oral amphetamine composition
ADARE PHARMACEUTICALS INC2 citations69
US10441554B2Oct 15, 2019
Oral amphetamine composition
ADARE PHARMACEUTICALS INC3 citations69
US11452689B2Sep 27, 2022
Taste-masked pharmaceutical compositions
ADARE PHARMACEUTICALS INC0 citations62
US12151028B2Nov 26, 2024
Drug delivery systems comprising solid solutions of weakly basic drugs
ADARE PHARMACEUTICALS INC0 citations61
VENKATESH GOPI M
8 patentsUS9161919B2Oct 20, 2015
Timed, pulsatile release systems
VENKATESH GOPI M30 citations97
US9161918B2Oct 20, 2015
Timed, pulsatile release systems
VENKATESH GOPI M28 citations97
US8545881B2Oct 1, 2013
Orally disintegrating tablets and methods of manufacture
VENKATESH GOPI M29 citations89
US9884014B2Feb 6, 2018
Taste-masked pharmaceutical compositions
VENKATESH GOPI M12 citations84
US8840925B2Sep 23, 2014
Orally disintegrating tablet compositions of lamotrigine
VENKATESH GOPI M7 citations82
US8747895B2Jun 10, 2014
Orally disintegrating tablets of atomoxetine
VENKATESH GOPI M17 citations82
US8137734B2Mar 20, 2012
Preparation of controlled release skeletal muscle relaxant dosage forms
VENKATESH GOPI M8 citations78
US8647656B2Feb 11, 2014
Orally disintegrating tablet compositions of lamotrigine
VENKATESH GOPI M1 citations61
ELLODI PHARMACEUTICALS L P
7 patentsUS11266598B2Mar 8, 2022
Orally administered corticosteroid compositions
ELLODI PHARMACEUTICALS L P6 citations84
US11260061B2Mar 1, 2022
Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
ELLODI PHARMACEUTICALS L P7 citations84
US11246828B2Feb 15, 2022
Orally administered corticosteroid compositions
ELLODI PHARMACEUTICALS L P6 citations84
US11166961B2Nov 9, 2021
Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
ELLODI PHARMACEUTICALS L P7 citations82
US12310976B2May 27, 2025
Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
ELLODI PHARMACEUTICALS L P1 citations73
US12290598B2May 6, 2025
Orally administered corticosteroid compositions
ELLODI PHARMACEUTICALS L P1 citations73
US12447157B2Oct 21, 2025
Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
ELLODI PHARMACEUTICALS L P0 citations61
EURAND PHARMACEUTICALS LTD
4 patentsUS6500454B1Dec 31, 2002
Timed, sustained release systems for propranolol
EURAND PHARMACEUTICALS LTD93 citations97
US6627223B2Sep 30, 2003
Timed pulsatile drug delivery systems
EURAND PHARMACEUTICALS LTD295 citations95
US6451345B1Sep 17, 2002
Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
EURAND PHARMACEUTICALS LTD54 citations95
US6663888B2Dec 16, 2003
Pulsatile release histamine H2 antagonist dosage form
EURAND PHARMACEUTICALS LTD81 citations94
APTALIS PHARMATECH INC
4 patentsUS8367111B2Feb 5, 2013
Extended release dosage forms of propranolol hydrochloride
APTALIS PHARMATECH INC15 citations82
US9089490B2Jul 28, 2015
Orally disintegrating tablets and methods of manufacture
APTALIS PHARMATECH INC4 citations69
US9399025B2Jul 26, 2016
Modified release dosage forms of skeletal muscle relaxants
APTALIS PHARMATECH INC0 citations51
US9375410B2Jun 28, 2016
Modified release dosage forms of skeletal muscle relaxants
APTALIS PHARMATECH INC0 citations51